An experimental drug to treat Ebola is being sent to two doctors in Liberia who have contracted the deadly disease, government sources said Tuesday.
The White House and US Food and Drug Administration approved the request for sample doses of ZMapp, a serum being developed by California-based Mapp Biopharmaceutical, the Liberian government said on its website.
“The experimental drugs are to be brought in the country by a representative of the US government later this week,” it said.
Liberian President Ellen Johnson Sirleaf had appealed directly to US President Barack Obama to approve the request.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.